Profile data is unavailable for this security.
About the company
Zhejiang Jiuzhou Pharmaceutical Co Ltd is a China-based company mainly engaged in the production, sales and service of chemical raw materials and intermediates. The Company is committed to providing one-stop customized pharmaceutical contract development and manufacturing organization (CDMO) services to global pharmaceutical companies, biotechnology companies, scientific research institutions, and others, including small molecule chemical drugs, peptide drugs, conjugated drugs and small nucleic acid drugs. The CDMO projects served by the Company involve therapeutic areas such as anti-tumor, anti-heart failure, anti-depression, treatment of Parkinson's disease, anti-lung cancer, anti-virus, anti-diabetes, and anti-respiratory system infection.
- Revenue in CNY (TTM)4.91bn
- Net income in CNY697.36m
- Incorporated1998
- Employees4.88k
- LocationZhejiang Jiuzhou Pharmaceutical Co LtdNo.99, Waisha Road, Jiaojiang DistrictTAIZHOU 318000ChinaCHN
- Phone+86 57 688706789
- Fax+86 57 688706788
- Websitehttp://www.jiuzhoupharma.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BrightGene Bio-Medical Technology Co Ltd | 1.24bn | 188.08m | 12.70bn | 1.16k | 67.31 | 5.39 | -- | 10.23 | 0.4466 | 0.4466 | 2.96 | 5.57 | 0.2522 | 1.63 | 3.50 | 1,074,862.00 | 2.91 | 6.53 | 3.57 | 7.93 | 54.97 | 56.93 | 11.55 | 19.90 | 1.18 | 4.53 | 0.4841 | 29.31 | 15.94 | 23.68 | -15.51 | 22.56 | 29.13 | -- |
| Jiang Zhong Pharmaceutical Co Ltd | 4.22bn | 753.16m | 13.24bn | 4.01k | 17.55 | 3.56 | -- | 3.14 | 1.20 | 1.20 | 6.71 | 5.91 | 0.6828 | 3.58 | 15.12 | 1,052,061.00 | 13.36 | 10.82 | 20.72 | 15.08 | 63.72 | 65.02 | 19.56 | 18.17 | 0.8833 | -- | 0.0004 | 82.88 | 13.00 | 20.12 | 18.40 | 8.54 | 11.47 | 40.99 |
| Chongqing Taiji Industry Group Co Ltd | 13.87bn | 609.10m | 14.31bn | 12.59k | 23.50 | 3.58 | -- | 1.03 | 1.09 | 1.09 | 24.91 | 7.18 | 0.9696 | 2.82 | 5.08 | 1,102,051.00 | 4.46 | 0.7814 | 12.44 | 2.35 | 42.31 | 44.03 | 4.60 | 0.8498 | 0.4665 | 5.50 | 0.5528 | 25.76 | 10.58 | 7.88 | 131.99 | 63.55 | 3.86 | 24.57 |
| Sunshine Guojian Pharmcutcl Shngh Co Ltd | 1.22bn | 363.75m | 14.49bn | 965.00 | 39.85 | 2.86 | -- | 11.85 | 0.5897 | 0.5897 | 1.98 | 8.23 | 0.2214 | 1.54 | 6.63 | 1,267,186.00 | 6.36 | 1.32 | 6.97 | 1.41 | 75.73 | 80.74 | 28.72 | 6.55 | 3.24 | -- | 0.0098 | 8.25 | 22.84 | -2.35 | 497.63 | -4.44 | 21.22 | -- |
| Zhejiang Jiuzhou Pharmaceutical Co Ltd | 4.91bn | 697.36m | 14.70bn | 4.88k | 21.09 | 1.72 | -- | 2.99 | 0.7749 | 0.7749 | 5.45 | 9.51 | 0.4405 | 1.75 | 4.20 | 1,007,191.00 | 6.28 | 10.10 | 7.67 | 13.69 | 32.61 | 34.64 | 14.25 | 16.26 | 2.48 | -- | 0.0909 | 40.79 | 1.44 | 24.29 | 12.20 | 45.74 | 32.14 | 20.11 |
| Zhejiang Medicine Co., Ltd. | 9.03bn | 977.95m | 15.86bn | 6.23k | 16.12 | 1.53 | -- | 1.76 | 1.02 | 1.02 | 9.54 | 10.75 | 0.694 | 2.94 | 6.01 | 1,450,206.00 | 6.57 | 4.32 | 8.36 | 5.68 | 36.63 | 36.57 | 9.46 | 6.28 | 1.78 | 26.62 | 0.0684 | 58.72 | -3.96 | 2.59 | -20.37 | 3.34 | 12.65 | 0.00 |
| Shanghai Shyndec Pharmaceutical Co Ltd | 11.50bn | 1.08bn | 16.23bn | 11.61k | 14.99 | 1.24 | -- | 1.41 | 0.8071 | 0.8071 | 8.58 | 9.75 | 0.588 | 3.11 | 7.16 | 990,814.20 | 6.99 | 4.85 | 10.16 | 8.17 | 37.73 | 43.00 | 11.88 | 7.03 | 2.03 | -- | 0.1012 | 17.52 | -6.86 | 1.29 | 10.21 | -0.3897 | -2.21 | 0.00 |
| Suzhou Zelgen Biopharmaceuticals Co Ltd | 488.45m | -174.40m | 16.36bn | 867.00 | -- | 12.56 | -- | 33.50 | -0.6692 | -0.6692 | 1.86 | 4.92 | 0.1677 | 0.2615 | 4.39 | 563,380.80 | -6.54 | -27.13 | -11.06 | -39.20 | 92.64 | 92.75 | -39.00 | -220.71 | 1.83 | -- | 0.4159 | -- | 27.83 | 211.81 | 39.08 | -- | 41.38 | -- |
Data as of Nov 01 2024. Currency figures normalised to Zhejiang Jiuzhou Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
14.79%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Zhong Ou Asset Management Co., Ltdas of 30 Sep 2023 | 63.81m | 7.68% |
| Hwabao WP Fund Management Co., Ltd.as of 30 Sep 2023 | 13.95m | 1.68% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 12.81m | 1.54% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2024 | 8.03m | 0.97% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 6.91m | 0.83% |
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2024 | 4.51m | 0.54% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024 | 3.35m | 0.40% |
| Guotai Asset Management Co., Ltd.as of 30 Jun 2024 | 3.29m | 0.40% |
| E Fund Management Co., Ltd.as of 30 Jun 2024 | 3.27m | 0.39% |
| China Fund Management Co., Ltd.as of 30 Jun 2024 | 3.02m | 0.36% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
